Lfng - LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase Gene
Species: Rattus norvegicus
Summary
Predicted to enable O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity. Predicted to be involved in lymphocyte differentiation; negative regulation of Notch signaling pathway involved in somitogenesis; and somitogenesis. Predicted to act upstream of or within several processes, including compartment pattern specification; positive regulation of Notch signaling pathway; and regulation of somitogenesis. Predicted to be integral component of Golgi membrane. Human ortholog(s) of this gene implicated in spondylocostal dysostosis. Orthologous to human LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). [provided by Alliance of Genome Resources, Apr 2022]
Lfng Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_133393.2 | NP_596884.1 | beta-1,3-N-acetylglucosaminyltransferase lunatic fringe precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
beta-1,3-N-acetylglucosaminyltransferase lunatic fringe |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS07601 | LFNG Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22217 | Lfng Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28739 | Lfng Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service